| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $75.3M | — | +22.8% |
| Cost of Revenue | $17.7M | — | +10.9% |
| Gross Profit | $57.6M | — | +27.1% |
| R&D Expense | $2.8M | — | +59.4% |
| SG&A Expense | $23.0M | — | +15.2% |
| Operating Income | -$1.5M | — | +66.2% |
| Pre-tax Income | -$896K | — | +78.0% |
| Income Tax | $867K | — | +179.0% |
| Net Income | -$1.8M | — | +40.7% |
| EPS (Basic) | -$0.08 | — | +38.5% |
| EPS (Diluted) | -$0.08 | — | +38.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $75.0M | -10.1% | -10.3% |
| Accounts Receivable | $38.2M | -12.9% | +7.1% |
| Inventory | $16.6M | +18.2% | -12.1% |
| Current Assets | $152.8M | -7.5% | -4.5% |
| Total Assets | $272.1M | -0.7% | -2.9% |
| Current Liabilities | $36.0M | -12.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$339K | — | -181.3% |
| Capital Expenditures | $821K | — | +116.6% |
| Investing Cash Flow | -$7.1M | — | -1634.9% |
| Financing Cash Flow | -$1.1M | — | +90.2% |
| Free Cash Flow | -$1.2M | — | -3152.6% |
| +1.7% |
| Long-term Debt | $0 | — | — |
| Total Liabilities | $54.3M | -1.4% | -27.3% |
| Stockholders' Equity | $217.9M | -0.5% | +5.9% |